Wang, Y., Jiang, T., Qin, Z., Jiang, J., Wang, Q., Yang, S., . . . Hirsch, F. (2019). HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Ann Oncol.
シカゴスタイル引用形Wang, Y., et al. "HER2 Exon 20 Insertions in Non-small-cell Lung Cancer Are Sensitive to the Irreversible Pan-HER Receptor Tyrosine Kinase Inhibitor Pyrotinib." Ann Oncol 2019.
MLA引用形式Wang, Y., et al. "HER2 Exon 20 Insertions in Non-small-cell Lung Cancer Are Sensitive to the Irreversible Pan-HER Receptor Tyrosine Kinase Inhibitor Pyrotinib." Ann Oncol 2019.
警告: この引用は必ずしも正確ではありません.